ACURA PHARMS INC (ACUR) SEC filings
ACUR SEC filings moved a median of 0.00% by the close. ACUR SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACUR overview →
43 measured ACUR SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K ACURA PHARMACEUTICALS, For: Oct 02 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Aug 14 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jul 17 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jun 29 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: May 05 | SEC filing · Form 8-K | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Mar 09 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jan 16 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Dec 23 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Oct 23 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Sep 03 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | +0.00% | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jul 18 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jun 20 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: May 29 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: May 15 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Apr 18 | SEC filing · Form 8-K | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Feb 28 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jan 13 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Dec 12 | SEC filing · Form 8-K | — | — | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | +0.00% | +17.71% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Nov 02 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Jun 30 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jul 22 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jun 28 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: May 31 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Mar 31 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: May 10 | SEC filing · Form 8-K | — | — | |
| Form NT 10-K ACURA PHARMACEUTICALS, For: Dec 31 | SEC filing · Form NT | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Mar 25 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Mar 14 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Feb 14 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jan 30 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Jan 08 | SEC filing · Form 8-K | — | — | |
| Form 8-K ACURA PHARMACEUTICALS, For: Dec 07 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K ACURA PHARMACEUTICALS, For: Dec 04 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form NT 10-Q ACURA PHARMACEUTICALS, For: Sep 30 | SEC filing · Form NT | — | — |
Keep exploring
More ACUR: earnings → · analyst actions → · ACUR overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REPLICEL LIFE SCIENCE ORD (REPCF) | 59 | 0.00% | 27% |
| REALM THERAPEUTICS PLC ADS (RLM) | 59 | 0.00% | 41% |
| ONCOBIOLOGICS (ONS) | 58 | 0.00% | 47% |
| BESPOKE EXTRACTS INC (BSPK) | 57 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.